Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial
Condition:   Acute Rhinosinusitis Interventions:   Drug: Mometasone Nasal 50 Mcg/Inh Nasal Spray;   Device: Nasal spray Sponsor:   Saffron Pharma Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2022 Category: Research Source Type: clinical trials